CME’s Legal Gambit Targets CFTC
The CME Group, the world’s largest derivatives exchange, is preparing to sue the Commodity Futures Trading Commission (CFTC) following the regulator’s approval of perpetual futures products earlier in June 2024. CME Chief Executive Terrence Duffy announced on CNBC’s “Fast Money” that the lawsuit would be filed Thursday, marking a rare legal challenge by a major U.S. exchange against its primary regulator. Duffy contends that the CFTC has overstepped its statutory authority by approving certain perpetual futures contracts, particularly those listed by prediction market Kalshi and permissions granted to Coinbase for connecting American users to offshore perpetuals.
Perpetual futures—often called “perps”—are cryptocurrency derivatives that do not expire and rely on funding payments exchanged between traders to keep prices anchored to spot markets. The CFTC’s decision in late May 2024 to greenlight these products for U.S. venues has triggered sharp opposition from the CME, which argues that such contracts should not be classified as futures under current law. According to decrypt.co, Duffy insists these products fall under the swaps category as defined by the Dodd-Frank Act, not as traditional futures.
Kalshi’s perpetual futures contract was approved by the CFTC in late May 2024, just weeks before CME announced its legal challenge.
Dodd-Frank at Center of Dispute
At the heart of CME’s lawsuit is a technical but consequential distinction: whether perpetual futures are legally “futures” or “swaps.” Under the Dodd-Frank Act, passed in 2010 after the financial crisis, swaps face stricter regulatory requirements than standard futures contracts. Duffy has repeatedly stated that the CFTC’s approval fails to meet these requirements and may be at odds with federal law governing derivatives oversight.
On paper, both swaps and futures are regulated by the CFTC, but their compliance obligations differ significantly. Duffy claims that by categorizing perps as futures rather than swaps, the agency is sidestepping crucial investor protections embedded in Dodd-Frank. This forms the core of CME’s legal argument and is expected to be a focal point in court filings.
The lawsuit comes just weeks after combined exchange volumes dropped 3.45% in May 2024 to $4.41 trillion—the lowest since September 2024—even as real-world asset (RWA) perpetual futures volumes surged 10.4% to new highs.
See Also
Regulatory Clash: Innovation vs. Oversight
The CFTC has responded forcefully to CME’s announcement. A spokesperson for the agency described the lawsuit as “frivolous” and accused CME of resorting to “lawfare” instead of competing in an evolving marketplace. The spokesperson also tied CME’s challenge to broader political dynamics, referencing what they called the Trump Administration’s “pro-innovation agenda.” This rhetorical clash underscores deeper tensions between established exchanges and regulators over how—and how quickly—crypto derivatives should be integrated into U.S. financial markets.
Meanwhile, CME itself has held back from listing its own perpetual futures contracts pending regulatory clarity. Duffy told CNBC on Wednesday that CME would need a clearer understanding of applicable rules before entering this segment of the market. For now, he says, “the rules are not clear,” leaving major players like CME on the sidelines even as rivals push forward with new product launches.
A notable micro-contrast emerges: While CFTC officials tout their approval as fostering innovation and competition, CME sees it as undermining legal safeguards established more than a decade ago.
Leadership Transition Amid Legal Storm
Adding another layer of complexity is CME’s leadership transition set for March 2027, when Terrence Duffy will step down after decades at the helm. Lynne Fitzpatrick, currently President and CFO, will become CME’s first female CEO at that time—a milestone for both company and industry. It remains uncertain how this impending change may influence strategic decisions around litigation or product launches.
Coincidentally, this legal battle unfolds as U.S. courts continue to wrestle with questions about regulatory jurisdiction over prediction markets and related products. On Wednesday—the same day Duffy spoke publicly about the lawsuit—a Michigan judge denied Polymarket’s request for an injunction against state regulators, ruling that sports-based prediction market bets are not swaps and thus fall outside CFTC purview. An appeals court is scheduled to revisit these jurisdictional issues next month.
As reported by decrypt.co, CME confirmed its intention to file suit against the CFTC this week, underscoring just how unsettled—and high-stakes—the debate over crypto derivatives regulation remains in mid-2024.
What remains to be seen
If CME Group files its lawsuit against the CFTC as announced for Thursday, the immediate outcome will hinge on whether a court agrees with CME CEO Terrence Duffy's argument that perpetual futures should be classified as swaps under the Dodd-Frank Act, which remains unclear at this stage.
